PSCHvsARKGETF Comparison
VS
Invesco S&P SmallCap Health Care ETF (PSCH) belongs to the US Health Care segment. ARK Genomic Revolution ETF (ARKG) is part of the BioTech & Genomics segment. Both ETFs have the same top 1 sector exposures: Healthcare. PSCH is less expensive with a Total Expense Ratio (TER) of 0.29%, versus 0.75% for ARKG. PSCH is up 21.86% year-to-date (YTD) with +$7M in YTD flows. ARKG performs better with 58.68% YTD performance, and +$113M in YTD flows. Run a side-by-side ETF comparison of PSCH and ARKG below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PSCH vs ARKG performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/09/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PSCH ARKG | -2.89%+4.46% | +13.44%+38.03% | +21.86%+58.68% | +30.10%+80.95% | +36.07%+46.94% | -13.90%-44.70% |
| Flows | PSCH ARKG | +$14M+$87M | +$25M+$201M | +$7M+$113M | +$2M+$128M | -$109M-$444M | -$207M-$2.19B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PSCH ARKG | +15.73%+43.15% | +19.67%+44.28% | +21.83%+43.95% | +22.87%+46.35% |
| Max drawdown | PSCH ARKG | -4.27%-13.89% | -15.36%-27.52% | -22.80%-46.41% | -45.76%-78.11% |
| Max drawdown duration | PSCH ARKG | 21d32d | 168d126d | 488d882d | 1766d1826d |
Trading data
PSCH | ARKG | |
Last sale 9/10/2026 at 1:30 PM | $53.11 | $45.38 |
| Previous close 09/09/2026 | $53.71 | $46.31 |
| Consolidated volume 09/09/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
ARKG
is actively managed and doesn’t replicate an indexPSCH | ARKG | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/10/2026 at 1:30 PM
Live
Closed
PSCH | ARKG | |
|---|---|---|
| Last price | $53.11 | $45.38 |
| 1D performance | -1.12% | -2.01% |
| AuM | $181.59 M | $1.94 B |
| E/R | 0.29% | 0.75% |
Characteristics
PSCH | ARKG | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | Invesco | Ark Investment |
| Benchmark | S&P SmallCap 600 Capped Health Care Index | - |
| N° of holdings | 69 | 31 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 7, 2010 | April 2, 2019 |
| ESG | No | No |
Advertisement
Exposure
Countries
PSCH
USA
95.04%
Other
4.96%
ARKG
USA
88.43%
Other
11.57%
Sectors
PSCH
Healthcare
100%
Other
0%
ARKG
Healthcare
97.99%
Other
2.01%
Advertisement
Diversification
PSCH
Total weight of top 15 holdings out of 15
48.1%
ARKG
Total weight of top 15 holdings out of 15
75.55%
Top 15 holdings
Data as of July 31, 2026
PSCH
Glaukos Corp.
4.96%
Corcept Therapeutics, Inc.
4.64%
Alkermes Plc
4.21%
Protagonist Therapeutics, Inc.
4.20%
TG Therapeutics, Inc.
3.68%
PTC Therapeutics, Inc.
3.23%
Liquidia Corp.
3.19%
Teleflex, Inc.
3.11%
Ligand Pharmaceuticals, Inc.
3.01%
Indivior Pharmaceuticals, Inc.
2.55%
Merit Medical Systems, Inc.
2.52%
RadNet, Inc.
2.34%
Veracyte, Inc.
2.32%
ICU Medical, Inc.
2.17%
Concentra Group Holdings Parent, Inc.
1.96%
ARKG
10X Genomics, Inc.
9.41%
Twist Bioscience Corp.
7.74%
Tempus AI, Inc.
6.57%
CRISPR Therapeutics AG
6.30%
Personalis, Inc.
5.48%
Absci Corp.
5.15%
Guardant Health, Inc.
4.75%
Illumina, Inc.
4.75%
Eli Lilly & Co.
4.69%
CareDx, Inc.
4.31%
Natera, Inc.
4.14%
Beam Therapeutics, Inc.
3.78%
Compass Pathways Plc
3.26%
Recursion Pharmaceuticals, Inc.
2.63%
Adaptive Biotechnologies Corp.
2.58%
Frequently asked questions about PSCH and ARKG
How have the PSCH and ARKG ETFs performed in 2026?
As of September 9, 2026, PSCH is up 21.86% year-to-date (YTD), while ARKG has returned 58.68%. That puts ARKG better performer ahead so far this year.
Which ETF is attracting more investor money: PSCH or ARKG?
Year-to-date, the PSCH ETF saw +$7M in flows, compared to +$113M for ARKG.
Which ETF is more volatile: PSCH or ARKG?
Over the past year, PSCH had a volatility of 19.67%, while ARKG experienced 44.28%.
Which ETF is bigger: PSCH or ARKG?
As of September 9, 2026, PSCH holds $181.59 M in assets under management (AUM), while ARKG manages $1.94 B.
What sectors do the PSCH and ARKG ETFs invest in?
PSCH leans toward sectors like Healthcare. Meanwhile, ARKG focuses on Healthcare.
What are the top holdings of the PSCH ETF and ARKG ETF?
PSCH top holdings include Glaukos Corp., Corcept Therapeutics, Inc. and Alkermes Plc. ARKG holds in its top three: 10X Genomics, Inc., Twist Bioscience Corp. and Tempus AI, Inc..
Which ETF is more diversified: PSCH or ARKG?
PSCH holds 69 securities with 48.1% of its assets in the top 15. ARKG has 31 securities and a top 15 weight of 75.55%.
Advertisement
Latest news about PSCH & ARKG
Advertisement
